Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132985) titled 'A multicenter, randomized, double-blind, double-dummy, parallel, active-controlled clinical trial to evaluate the efficacy and safety of morphine sulfate extended-release capsules in patients with moderate to severe cancer pain' on Sept. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: zhengzhou Third People's Hospital
Condition:
Indicated for treatment of pain severe enough to require daily, continuous, long-term opioid therapy with inadequate alternative options
Intervention:
Investigational drug:oral Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules
Re...